RSLS Insider Trading Activity and SEC Form 4 Filings
RSLS insider trading summary
No open-market insider purchases or sales of ReShape Lifesciences Inc. (RSLS) have been reported on SEC Form 4 in the past 12 months.
Latest RSLS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 31, 2024 | Thomas Stankovich | Chief Financial Officer | Sell | $12 (48 @ $0.25) |
| Feb 29, 2024 | Thomas Stankovich | Chief Financial Officer | Sell | $7 (43 @ $0.17) |
| Dec 31, 2023 | Thomas Stankovich | Chief Financial Officer | Sell | $11 (42 @ $0.25) |
| Nov 30, 2023 | Thomas Stankovich | Chief Financial Officer | Sell | $9 (39 @ $0.23) |
| Oct 25, 2023 | Thomas Stankovich | Chief Financial Officer | Sell | $35 (131 @ $0.27) |
| Oct 11, 2023 | Thomas Stankovich | Chief Financial Officer | Sell | $36 (39 @ $0.93) |
| Sep 1, 2023 | Thomas Stankovich | Chief Financial Officer | Sell | $105 (118 @ $0.89) |
| Aug 24, 2023 | Thomas Stankovich | Chief Financial Officer | Sell | $55 (39 @ $1.42) |
| Aug 4, 2023 | Thomas Stankovich | Chief Financial Officer | Sell | $154 (108 @ $1.43) |
| Jul 6, 2023 | Thomas Stankovich | Chief Financial Officer | Sell | $156 (106 @ $1.47) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.